Gainers

  • Crinetics Pharmaceuticals (NASDAQ:CRNX) stock increased by 17.7% to $35.0 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.7 billion.
  • Iovance Biotherapeutics (NASDAQ:IOVA) stock moved upwards by 14.0% to $2.85. The market value of their outstanding shares is at $904.6 million.
  • NRX Pharmaceuticals (NASDAQ:NRXP) shares moved upwards by 11.14% to $3.07. The market value of their outstanding shares is at $53.8 million. The company's, Q2 earnings came out yesterday.
  • PharmaCyte Biotech (NASDAQ:PMCB) stock rose 8.91% to $1.1. The market value of their outstanding shares is at $6.9 million.
  • Senti Biosciences (NASDAQ:SNTI) stock increased by 8.74% to $1.74. The market value of their outstanding shares is at $41.8 million.
  • Bone Biologics (NASDAQ:BBLG) shares increased by 8.17% to $2.25. The market value of their outstanding shares is at $3.3 million. As per the news, the Q2 earnings report came out 3 days ago.

Losers

  • Viking Therapeutics (NASDAQ:VKTX) stock declined by 29.5% to $29.67 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.7 billion.
  • iBio (NASDAQ:IBIO) shares declined by 17.83% to $0.61. The company's market cap stands at $12.0 million.
  • ALX Oncology Holdings (NASDAQ:ALXO) stock fell 17.51% to $0.8. The market value of their outstanding shares is at $51.9 million.
  • Propanc Biopharma (NASDAQ:PPCB) stock fell 15.73% to $4.93. The market value of their outstanding shares is at $67.9 million.
  • Soligenix (NASDAQ:SNGX) stock decreased by 15.33% to $4.2. The company's market cap stands at $16.1 million. As per the news, the Q2 earnings report came out 3 days ago.
  • ModivCare (NASDAQ:MODV) stock declined by 13.59% to $2.1. The company's market cap stands at $34.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Comments
Loading...